Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Nicola Stefano Fracchiolla et al.|The Lancet Haematology|2020Cited by 553
Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMTMohamad Mohty, Jaime Sanz, Jacques‐Emmanuel Galimard et al.|Journal of Hematology & Oncology|2020Cited by 117
Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow TransplantationMaurizio Miano, Myriam Labopin, Olivier Hartmann et al.|Bone Marrow Transplantation|2007Cited by 116
Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell TransplantationShalini Shenoy, Mark C. Walters, Emanuele Angelucci et al.|Biology of Blood and Marrow Transplantation|2017Cited by 85
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoringMałgorzata Mikulska, Matteo Bassetti, Monica Melchio et al.|Journal of Antimicrobial Chemotherapy|2024Cited by 26